Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)

The Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) aims to stimulate partnerships between life and physical science fields. It focuses on solutions to biomedical issues using a multidisciplinary bioengineering approach. Furthermore, it supports projects that aim to enhance the utilization of promising tools, methods, and techniques in basic, translational, or clinical science and practice.

The funding opportunity is also open to a range of research types, such as design-oriented, developmental, discovery-led, or hypothesis-driven research. It is ideally suited for small teams that employ an integrative method to enhance our insight into and tackle issues in biological, clinical, or translational science. The primary objective of this grant is to speed up the adoption and validation of these tools and methodologies to solve complex issues in these research fields.